Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics

Cancer vaccines and oncolytic immunotherapy are promising treatment strategies with potential to provide greater clinical benefit to patients with advanced-stage cancer. In particular, recombinant vaccinia viruses (VV) hold great promise as interventional agents. In this article, we first summarize...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Zong Sheng, Lu, Binfeng, Guo, Zongbi, Giehl, Esther, Feist, Mathilde, Dai, Enyong, Liu, Weilin, Storkus, Walter J., He, Yukai, Liu, Zuqiang, Bartlett, David L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325819/
https://www.ncbi.nlm.nih.gov/pubmed/30626434
http://dx.doi.org/10.1186/s40425-018-0495-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325819/
https://www.ncbi.nlm.nih.gov/pubmed/30626434
http://dx.doi.org/10.1186/s40425-018-0495-7

Ejemplares similares